Newsmeme!
Discover News you didn't know existed

• home
• news
• tagging
• how it works
• about
• data

Sarcoma

News

Clinical Trials Update: Dec. 2, 2008

Published December 2, 2008, 9:02 am, HealthDay via Yahoo! News

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery

Related Sarcoma Stories

From Various News Sources

Oxygen Biotherapeutics, Inc. Provides Update on Product Development ... - Phramalive.com
COSTA MESA, Calif.--(BUSINESS WIRE)--Dec 2, 2008 - Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) has posted an Update on the company website that discusses the company's development plans for Oxycyte®. Oxycyte is the company's perfluorocarbon (PFC ...

Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination ... - Marketwatch
GENEVA, Dec 02, 2008 (MARKET WIRE via COMTEX) -- Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, started today a Phase IIb trial of ADX10059 as an add-on therapy to proton pump inhibitors (PPIs) for the treatment of ...

Protalix BioTherapeutics Announces Completion of Enrollment for its ... - Phramalive.com
CARMIEL, Israel--(BUSINESS WIRE)--Dec 2, 2008 - Protalix BioTherapeutics, Inc. (Amex: PLX), announced today that it has completed enrollment in the Company's pivotal phase III clinical trial of prGCD, a proprietary plant cell expressed recombinant ...

Clinical Trial Results on the Sleep-Promoting Effects of Vanda ... - Yahoo Finance
ROCKVILLE, Md., Dec. 1 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News ) reports publication in The Lancet , one of the world's leading medical journals, results of clinical trials of its novel circadian regulator ...

Vion Pharmaceuticals Adds Tanya Lewis to Senior Management Team - Earthtimes
Author : Vion Pharmaceuticals, Inc. NEW HAVEN, Conn. , Dec. 2 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced that Tanya Lewis had joined its senior management team as Vice President, Regulatory and ...

Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results - Earthtimes
Author : Neovasc Inc. RICHMOND, BC , Dec. 1 /PRNewswire-FirstCall/ - Neovasc Inc. (TSXV: NVC), a new specialty vascular device company, today announced financial results for the third quarter and nine months ended September 30, 2008 . Neovasc Chief ...

VirtualScopics Backlog Rises to a Record $27 Million - PR Newswire
ROCHESTER, N.Y., Dec. 2 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (NASDAQ: VSCP) , a leading provider of quantitative imaging for clinical trials, today announced that its backlog currently exceeds $27 million compared to $14.7 million at the ...

Generex Announces Positive Results of Metformin Chewing Gum Trial - MSN MoneyCentral
WORCESTER, Mass., Dec. 2, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced results from a clinical ...

UPDATE 1-Virus concern over Solvay enzyme drug - FDA staff - Reuters
WASHINGTON, Nov 28 (Reuters) - The risk of contracting viruses from pig glands used to make Solvay Pharmaceuticals Inc's pancreatic enzyme drug Creon should be lowered, U.S. Food and Drug Administration staff said in documents released on Friday. The ...

ANA598 Receives Fast Track Designation From the FDA for the Treatment ... - StreetInsider.com
December 1, 2008 6:38 PM EST SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of ...

Related Social Bookmarks

None found at this time.